Veterinary Vaccines Market by Type (Porcine, Poultry, Livestock, Companion Animals), Technology (Live Attenuated, Inactivated, Toxoid), Route of Administration (Intramuscular, Subcutaneous, Oral), End user (Hospitals, Clinics) - Global Forecast to 2029

1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Market Segmentation & Geographical Spread
1.3.2 Inclusions & Exclusions
1.3.3 Years Considered
1.3.4 Currency Considered
1.4 Stakeholders
1.5 Summary of Changes

2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Secondary Sources
2.1.1.2 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Primary Sources
2.1.2.2 Objectives of Primary Research
2.1.2.3 Key Data from Primary Sources
2.1.2.4 Key Industry Insights
2.1.2.5 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Supply-Side Analysis (Revenue Share Analysis)
2.2.2 Company Presentations and Primary Interviews
2.2.3 Top-Down Approach
2.3 Data Triangulation
2.4 Market Share Analysis
2.5 Study Assumptions
2.6 Risk Assessment
2.7 Research Limitations
2.7.1 Methodology-Related Limitations
2.7.2 Scope-Related Limitations

4.1 Veterinary Vaccines Market Overview
4.2 Asia-Pacific: Veterinary Vaccines Market, by Technology and Country (2023)
4.3 Veterinary Vaccines Market: Geographic Growth Opportunities

5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rise in Companion Animal Population and Pet Ownership
5.2.1.2 Increasing Incidence of Infectious Zoonotic Diseases
5.2.1.3 Favorable Initiatives by Government Agencies and Animal Associations
5.2.1.4 Growing Demand for Animal-Derived Food Products
5.2.1.5 Increased Adoption of Pet Insurance and High Animal Health Expenditure
5.2.2 Restraints
5.2.2.1 High Cost of Vaccine Development
5.2.3 Opportunities
5.2.3.1 Technological Advancements for Veterinary Vaccine Development
5.2.3.2 Untapped Growth Potential in Emerging Economies
5.2.4 Challenges
5.2.4.1 Limited Awareness About Animal Vaccines and Shortage of Trained Veterinarians in Low-Income Countries
5.2.4.2 Stringent Regulatory Requirements for Licensing Veterinary Vaccines
5.3 Industry Trends
5.4 Technology Analysis
5.4.1 Key Technologies
5.4.1.1 Recombinant DNA Technology
5.4.1.2 Mrna-based Vaccines
5.4.2 Complementary Technologies
5.4.2.1 Vaccine Adjuvant Technology
5.4.2.2 Needle-Free and Microneedle Technology
5.4.3 Adjacent Technologies
5.4.3.1 Genome Editing Technology
5.5 Trends/Disruptions Impacting Customer's Business
5.6 Supply Chain Analysis
5.7 Value Chain Analysis
5.8 Trade Analysis
5.8.1 Import Data for HS Code 300242
5.8.2 Export Data for HS Code 300230
5.9 Porter's Five Forces Analysis
5.9.1 Threat of New Entrants
5.9.2 Threat of Substitutes
5.9.3 Bargaining Power of Suppliers
5.9.4 Bargaining Power of Buyers
5.9.5 Intensity of Competitive Rivalry
5.10 Key Stakeholders & Buying Criteria
5.10.1 Key Stakeholders in Buying Process
5.10.2 Key Buying Criteria
5.11 Regulatory Analysis
5.11.1 Regulatory Bodies, Government Agencies, and Other Organizations
5.11.2 Regulatory Framework
5.11.2.1 North America
5.11.2.1.1 US
5.11.2.2 Europe
5.11.2.3 Rest of the World
5.11.2.3.1 China
5.11.2.3.2 Brazil
5.11.2.3.3 Australia
5.12 Patent Analysis
5.12.1 Jurisdiction and Top Applicant Analysis
5.13 Pricing Analysis
5.13.1 Average Selling Price Trend of Veterinary Vaccines, by Key Player, 2021-2023
5.13.2 Average Selling Price Trend, by Region, 2021-2023
5.14 Key Conferences & Events, 2024-2026
5.15 Ecosystem Analysis
5.16 Case Study Analysis
5.17 Reimbursement Analysis
5.18 Unmet Needs/End-user Expectations
5.19 Impact of AI/Gen AI on Veterinary Vaccines Market
5.20 Investment & Funding Scenario
5.21 Pipeline Analysis

6.1 Introduction
6.2 Livestock Vaccines
6.2.1 Bovine Vaccines
6.2.1.1 Increasing Demand for Meat and Milk to Drive Market
6.2.2 Small Ruminant Vaccines
6.2.2.1 Increased Livestock Population and Favorable Government Initiatives to Propel Market Growth
6.3 Porcine Vaccines
6.3.1 Growing Awareness About Animal Vaccination to Support Market Growth
6.4 Poultry Vaccines
6.4.1 High Need for Protein in Daily Diet to Augment Market Growth
6.5 Companion Animal Vaccines
6.5.1 Canine Vaccines
6.5.1.1 Increasing Number of Pet Dogs and Growing Prevalence of Zoonotic Diseases to Spur Market Growth
6.5.2 Feline Vaccines
6.5.2.1 Rising Adoption of Cats and Growing Need for Better Veterinary Care to Boost Market Growth
6.6 Aquaculture Vaccines
6.6.1 Increased Popularity of Commercial Fish Farming to Fuel Market Growth
6.7 Other Veterinary Vaccines

7.1 Introduction
7.2 Livestock Diseases
7.2.1 Bovine Diseases
7.2.1.1 Favorable Government Programs and Increased Awareness About Animal Health in Emerging Economies to Aid Market Growth
7.2.2 Small Ruminant Diseases
7.2.2.1 New Vaccine Formulations and Improved Delivery Methods to Propel Vaccine Demand for Small Ruminants
7.3 Porcine Diseases
7.3.1 Increased Focus on Large-Scale Industrial Breeding of Pigs to Aid Market Growth
7.4 Poultry Diseases
7.4.1 Ongoing Risk of Avian Influenza Outbreaks to Spur Need for Poultry Vaccines
7.5 Companion Animal Diseases
7.5.1 Canine Diseases
7.5.1.1 Rise in Pet Ownership in Emerging Economies to Boost Market Growth
7.5.2 Feline Diseases
7.5.2.1 Rise in Cat Population in Urban Areas to Drive Demand for Feline Disease Management Programs
7.6 Aquaculture Diseases
7.6.1 Need for Preventive Healthcare and Biosecurity to Support Market Growth
7.7 Other Veterinary Diseases

8.1 Introduction
8.2 Live Attenuated Vaccines
8.2.1 Ease of Administration and Long-Term Immunity to Support Market Growth
8.3 Inactivated Vaccines
8.3.1 Need to Develop Artificial Immunity from Non-Living Pathogens to Drive Market
8.4 Toxoid Vaccines
8.4.1 Toxoid Vaccines to Stimulate Immune System and Protect Animals from Bacterial Toxins
8.5 Recombinant Vaccines
8.5.1 Better Stability, Higher Safety, and No Post-Vaccination Reactions to Support Vaccine Adoption
8.6 Other Vaccine Technologies

9.1 Introduction
9.2 Subcutaneous Route of Administration
9.2.1 Ease of Administration, Reduced Pain, and Lower Risk of Tissue Damage to Aid Market Growth
9.3 Intramuscular Route of Administration
9.3.1 Better Immune Response and Lower Rate of Injection-Site Reactions to Augment Market Growth
9.4 Oral Route of Administration
9.4.1 Cost-Effectiveness, Increased Safety, and High Patient Acceptability to Support Market Growth
9.5 Intranasal/Spray Route of Administration
9.5.1 Cost-Effectiveness and Rapid Absorption of Medicine to Aid in Mass Vaccination
9.6 Intraocular Route of Administration
9.6.1 Simple Administration of Vaccines in Large-Scale Farming Operations to Aid Market Growth
9.7 Other Routes of Administration

10.1 Introduction
10.2 Veterinary Hospitals
10.2.1 Growing Awareness About Animal Health and Increasing Veterinary Expenditure by Pet Owners to Drive Market
10.3 Veterinary Clinics
10.3.1 Rising Number of Pet Visits to Private Clinics to Spur Market Growth
10.4 Other End-users

11.1 Introduction
11.2 Asia-Pacific
11.2.1 Macroeconomic Outlook for Asia-Pacific
11.2.2 China
11.2.2.1 Increasing Companion Animal Population and Growing Incidence of Zoonotic Diseases to Drive Market
11.2.3 Japan
11.2.3.1 High Consumption of Animal-Derived Products and Increased Pet Health Expenditure to Propel Market Growth
11.2.4 India
11.2.4.1 Growth in Poultry Industry and High Demand for Dairy Products to Augment Market Growth
11.2.5 Australia
11.2.5.1 Increase in Per Capita Income and Rise in Meat Consumption to Aid Market Growth
11.2.6 South Korea
11.2.6.1 High Demand for Animal Protein and Favorable Government Subsidies for Meat Production to Spur Market Growth
11.2.7 New Zealand
11.2.7.1 Favorable Government Initiatives and Increased Incidence of Livestock Diseases to Boost Market Growth
11.2.8 Rest of Asia-Pacific
11.3 North America
11.3.1 Macroeconomic Outlook for North America
11.3.2 US
11.3.2.1 US to Dominate North American Veterinary Vaccines Market During Forecast Period
11.3.3 Canada
11.3.3.1 Rising Pet Ownership and Increasing Chicken Consumption to Drive Demand for Veterinary Vaccines
11.4 Europe
11.4.1 Macroeconomic Outlook for Europe
11.4.2 Germany
11.4.2.1 Increased Poultry Consumption and High Pet Healthcare Expenditure to Drive Market
11.4.3 UK
11.4.3.1 Rising Adoption of Pets to Augment Market Growth
11.4.4 France
11.4.4.1 Rising Companion Animal and Livestock Population to Boost Market Growth
11.4.5 Italy
11.4.5.1 Better Availability of Pet Products Through Large-Scale Outlets to Augment Market Growth
11.4.6 Spain
11.4.6.1 Increase in Veterinary Practices and Willingness to Spend on Animal Healthcare to Drive Market
11.4.7 Netherlands
11.4.7.1 High Demand for Meat and Increased Pressure on Sustainable Farming Practices to Fuel Market Growth
11.4.8 Rest of Europe
11.5 Latin America
11.5.1 Macroeconomic Outlook for Latin America
11.5.2 Brazil
11.5.2.1 Well-Established Livestock Industry to Promote Market Growth
11.5.3 Mexico
11.5.3.1 Focus on Pork and Poultry Meat Production to Fuel Market Growth
11.5.4 Rest of Latin America
11.6 Middle East & Africa
11.6.1 Macroeconomic Outlook for Middle East & Africa
11.6.2 GCC Countries
11.6.2.1 Kingdom of Saudi Arabia
11.6.2.1.1 Favorable Government Initiatives for Better Animal Health Infrastructure to Propel Market Growth
11.6.2.2 UAE
11.6.2.2.1 Favorable Government Initiatives to Safeguard National Livestock Population and Support Sustainable Agriculture
11.6.2.3 Rest of GCC Countries
11.6.3 Rest of Middle East & Africa

12.1 Introduction
12.2 Key Player Strategies/Right to Win
12.2.1 Overview of Strategies Adopted by Key Players
12.3 Revenue Analysis, 2019-2023
12.4 Market Share Analysis, 2023
12.4.1 Ranking of Key Market Players, 2O23
12.5 Company Evaluation Matrix: Key Players, 2023
12.5.1 Stars
12.5.2 Emerging Leaders
12.5.3 Pervasive Players
12.5.4 Participants
12.5.5 Company Footprint: Key Players, 2023
12.5.5.1 Company Footprint
12.5.5.2 Region Footprint
12.5.5.3 Type Footprint
12.5.5.4 Disease Footprint
12.5.5.5 Technology Footprint
12.6 Company Evaluation Matrix: Startups/SMEs, 2023
12.6.1 Progressive Companies
12.6.2 Responsive Companies
12.6.3 Dynamic Companies
12.6.4 Starting Blocks
12.6.5 Competitive Benchmarking: Startups/SMEs, 2023
12.7 Brand/Product Comparison
12.8 R&D Expenditure of Key Players
12.9 Company Valuation & Financial Metrics
12.9.1 Financial Metrics
12.9.2 Company Valuation
12.10 Competitive Scenario
12.10.1 Product Launches & Approvals
12.10.2 Deals
12.10.3 Expansions
12.10.4 Other Developments

13.1 Key Players
13.1.1 Merck & Co. Inc.
13.1.1.1 Business Overview
13.1.1.2 Products Offered
13.1.1.3 Recent Developments
13.1.1.3.1 Product Launches & Approvals
13.1.1.3.2 Deals
13.1.1.3.3 Expansions
13.1.1.3.4 Other Developments
13.1.1.4 Analyst's View
13.1.1.4.1 Right to Win
13.1.1.4.2 Strategic Choices
13.1.1.4.3 Weaknesses & Competitive Threats
13.1.2 Zoetis
13.1.2.1 Business Overview
13.1.2.2 Products Offered
13.1.2.3 Recent Developments
13.1.2.3.1 Product Launches
13.1.2.3.2 Deals
13.1.2.3.3 Expansions
13.1.2.3.4 Other Developments
13.1.2.4 Analyst's View
13.1.2.4.1 Right to Win
13.1.2.4.2 Strategic Choices
13.1.2.4.3 Weaknesses & Competitive Threats
13.1.3 Boehringer Ingelheim International GmbH
13.1.3.1 Business Overview
13.1.3.2 Products Offered
13.1.3.3 Recent Developments
13.1.3.3.1 Product Launches
13.1.3.3.2 Expansions
13.1.3.4 Analyst's View
13.1.3.4.1 Right to Win
13.1.3.4.2 Strategic Choices
13.1.3.4.3 Weaknesses & Competitive Threats
13.1.4 Elanco
13.1.4.1 Business Overview
13.1.4.2 Products Offered
13.1.4.3 Recent Developments
13.1.4.3.1 Deals
13.1.5 Ceva
13.1.5.1 Business Overview
13.1.5.2 Products Offered
13.1.5.3 Recent Developments
13.1.5.3.1 Deals
13.1.5.3.2 Expansions
13.1.6 Virbac
13.1.6.1 Business Overview
13.1.6.2 Products Offered
13.1.6.3 Recent Developments
13.1.6.3.1 Product Launches
13.1.6.3.2 Deals
13.1.6.3.3 Expansions
13.1.6.3.4 Other Developments
13.1.7 Phibro Animal Health Corporation
13.1.7.1 Business Overview
13.1.7.2 Products Offered
13.1.8 Hester Biosciences Limited
13.1.8.1 Business Overview
13.1.8.2 Products Offered
13.1.8.3 Recent Developments
13.1.8.3.1 Deals
13.1.9 Neogen Corporation
13.1.9.1 Business Overview
13.1.9.2 Products Offered
13.1.9.3 Recent Developments
13.1.9.3.1 Deals
13.1.10 Hipra
13.1.10.1 Business Overview
13.1.10.2 Products Offered
13.1.10.3 Recent Developments
13.1.10.3.1 Product Launches
13.1.11 Biogénesis Bagó
13.1.11.1 Business Overview
13.1.11.2 Products Offered
13.1.11.3 Recent Developments
13.1.11.3.1 Expansions
13.1.12 Tianjin Ringpu Bio-Technology Co. Ltd.
13.1.12.1 Business Overview
13.1.12.2 Products Offered
13.1.12.3 Recent Developments
13.1.12.3.1 Deals
13.1.13 China Animal Husbandry Industry Co. Ltd.
13.1.13.1 Business Overview
13.1.13.2 Products Offered
13.1.14 Jinyu Bio-Technology Co. Ltd.
13.1.14.1 Business Overview
13.1.14.2 Products Offered
13.1.14.3 Recent Developments
13.1.14.3.1 Product Approvals
13.1.15 Vaxxinova International B.V.
13.1.15.1 Business Overview
13.1.15.2 Products Offered
13.1.15.3 Recent Developments
13.1.15.3.1 Product Approvals
13.1.15.3.2 Expansions
13.2 Other Companies
13.2.1 Endovac Animal Health
13.2.2 Brilliant Bio Pharma
13.2.3 Aptimmune
13.2.4 Indian Immunologicals Ltd.
13.2.5 Torigen Pharmaceuticals Inc.
13.2.6 Intas Pharmaceuticals Ltd.
13.2.7 Ourofino Animal Health
13.2.8 Biovac Ltd.
13.2.9 Laboratoire Lcv
13.2.10 Kyoritsu Seiyaku Corporation

14.1 Discussion Guide
14.2 Knowledgestore: The Subscription Portal
14.3 Customization Options

Table 1 Veterinary Vaccines Market: Inclusions & Exclusions
Table 2 Standard Currency Conversion Rates
Table 3 Veterinary Vaccines Market: Study Assumptions
Table 4 Veterinary Vaccines Market: Risk Assessment Analysis
Table 5 Pet (Dogs and Cats) Ownership in US, 2024
Table 6 Major Outbreaks of Zoonotic Diseases, 2022-2023
Table 7 Past and Projected Trends in Consumption of Meat and Milk in Developed Countries
Table 8 Asia: Country-Level Consumption of Animal-Derived Food Products, 2020 vs. 2030 (Thousand Metric Tons)
Table 9 Asia: Country-Level Production of Animal-Derived Food Products, 2020 vs. 2030 (Thousand Metric Tons)
Table 10 Key Commercial Products Using Recombinant DNA Technology
Table 11 Import Data for HS Code 300230, by Country, 2019-2023 (USD Thousand)
Table 12 Export Value for HS Code 300230, by Country, 2019-2023 (USD Thousand)
Table 13 Veterinary Vaccines Market: Porter's Five Forces
Table 14 Influence of Key Stakeholders on Buying Process of Veterinary Vaccines, by End-user
Table 15 Key Buying Criteria for End-users
Table 16 North America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 17 Europe: Regulatory Bodies, Government Agencies, and Other Organizations
Table 18 Rest of the World: Regulatory Bodies, Government Agencies, and Other Organizations
Table 19 Veterinary Vaccines Market: List of Granted Patents, 2022-2023
Table 20 Average Selling Price Trend of Veterinary Vaccines, by Key Player, 2021-2023
Table 21 Average Selling Price Trend of Canine Vaccines (Per Dose), by Region, 2021-2023
Table 22 Average Selling Price Trend of Livestock Vaccines (Per Dose) by Region, 2021-2023
Table 23 Veterinary Vaccines Market: Detailed List of Key Conferences & Events, January 2024-December 2026
Table 24 Veterinary Vaccines Market: Role in Ecosystem
Table 25 Case Study 1: Supporting Innovation in Livestock Vaccines
Table 26 Case Study 2: Impact of A19 Vaccination on Livestock Health and Productivity
Table 27 Case Study 3: Development of Canine Vaccines for Valley Fever
Table 28 Veterinary Vaccines Market: Unmet Needs/End-user Expectations
Table 29 Veterinary Vaccines Market: Pipeline Analysis
Table 30 Veterinary Vaccines Market, by Type, 2022-2029 (USD Million)
Table 31 Livestock Vaccines Market, by Type, 2022-2029 (USD Million)
Table 32 Livestock Vaccines Market, by Country, 2022-2029 (USD Million)
Table 33 Commercial Bovine Vaccines by Key Manufacturers
Table 34 Bovine Vaccines Market, by Country, 2022-2029 (USD Million)
Table 35 Commercial Small Ruminant Vaccines by Key Manufacturers
Table 36 Small Ruminant Vaccines Market, by Country, 2022-2029 (USD Million)
Table 37 Commercial Porcine Vaccines by Key Manufacturers
Table 38 Porcine Vaccines Market, by Country, 2022-2029 (USD Million)
Table 39 Commercial Poultry Vaccines by Key Manufacturers
Table 40 Poultry Vaccines Market, by Country, 2022-2029 (USD Million)
Table 41 Companion Animal Vaccines Market, by Type, 2022-2029 (USD Million)
Table 42 Companion Animal Vaccines Market, by Country, 2022-2029 (USD Million)
Table 43 Commercial Canine Vaccines by Key Manufacturers
Table 44 Canine Vaccines Market, by Country, 2022-2029 (USD Million)
Table 45 Commercial Feline Vaccines by Key Manufacturers
Table 46 Feline Vaccines Market, by Country, 2022-2029 (USD Million)
Table 47 Commercial Aquaculture Vaccines by Key Manufacturers
Table 48 Aquaculture Vaccines Market, by Country, 2022-2029 (USD Million)
Table 49 Other Commercial Veterinary Vaccines by Key Manufacturers
Table 50 Other Veterinary Vaccines Market, by Country, 2022-2029 (USD Million)
Table 51 Veterinary Vaccines Market, by Disease, 2022-2029 (USD Million)
Table 52 Veterinary Vaccines Market for Livestock Diseases, by Type, 2022-2029 (USD Million)
Table 53 Veterinary Vaccines Market for Livestock Diseases, by Country, 2022-2029 (USD Million)
Table 54 Bovine Diseases Market, by Country, 2022-2029 (USD Million)
Table 55 Small Ruminant Diseases Market, by Country, 2022-2029 (USD Million)
Table 56 Veterinary Vaccines Market for Porcine Diseases, by Country, 2022-2029 (USD Million)
Table 57 Veterinary Vaccines Market for Poultry Diseases, by Country, 2022-2029 (USD Million)
Table 58 Veterinary Vaccines Market for Companion Animal Diseases, by Type, 2022-2029 (USD Million)
Table 59 Veterinary Vaccines Market for Companion Animal Diseases, by Country, 2022-2029 (USD Million)
Table 60 Canine Diseases Market, by Country, 2022-2029 (USD Million)
Table 61 Feline Diseases Market, by Country, 2022-2029 (USD Million)
Table 62 Veterinary Vaccines Market for Aquaculture Diseases, by Country, 2022-2029 (USD Million)
Table 63 Veterinary Vaccines Market for Other Veterinary Diseases, by Country, 2022-2029 (USD Million)
Table 64 Veterinary Vaccines Market, by Technology, 2022-2029 (USD Million)
Table 65 Commercially Available Key Live Attenuated Vaccines
Table 66 Live Attenuated Vaccines Market, by Country, 2022-2029 (USD Million)
Table 67 Commercially Available Key Inactivated Vaccines
Table 68 Inactivated Vaccines Market, by Country, 2022-2029 (USD Million)
Table 69 Commercially Available Key Toxoid Vaccines
Table 70 Toxoid Vaccines Market, by Country, 2022-2029 (USD Million)
Table 71 Commercially Available Key Recombinant Vaccines
Table 72 Recombinant Vaccines Market, by Country, 2022-2029 (USD Million)
Table 73 Commercially Available Other Key Vaccine Technologies
Table 74 Other Vaccine Technologies Market, by Country, 2022-2029 (USD Million)
Table 75 Routes of Administration for Major Veterinary Vaccines, by Key Player
Table 76 Veterinary Vaccines Market, by Route of Administration, 2022-2029 (USD Million)
Table 77 Commercially Available Vaccines with Subcutaneous Route of Administration
Table 78 Veterinary Vaccines Market for Subcutaneous Route of Administration, by Country, 2022-2029 (USD Million)
Table 79 Commercially Available Vaccines with Intramuscular Route of Administration
Table 80 Veterinary Vaccines Market for Intramuscular Route of Administration, by Country, 2022-2029 (USD Million)
Table 81 Commercially Available Vaccines with Oral Route of Administration
Table 82 Veterinary Vaccines Market for Oral Route of Administration, by Country, 2022-2029 (USD Million)
Table 83 Commercially Available Vaccines with Intranasal/Spray Route of Administration
Table 84 Veterinary Vaccines Market for Intranasal/Spray Route of Administration, by Country, 2022-2029 (USD Million)
Table 85 Commercially Available Vaccines with Intraocular Route of Administration
Table 86 Veterinary Vaccines Market for Intraocular Route of Administration, by Country, 2022-2029 (USD Million)
Table 87 Commercially Available Vaccines with Other Routes of Administration
Table 88 Veterinary Vaccines Market for Other Routes of Administration, by Country, 2022-2029 (USD Million)
Table 89 Veterinary Vaccines Market, by End-user, 2022-2029 (USD Million)
Table 90 Veterinary Hospitals Market, by Country, 2022-2029 (USD Million)
Table 91 Veterinary Clinics Market, by Country, 2022-2029 (USD Million)
Table 92 Other End-users Market, by Country, 2022-2029 (USD Million)
Table 93 Veterinary Vaccines Market, by Region, 2022-2029 (USD Million)
Table 94 Porcine Vaccines Market, by Region, 2022-2029 (Million Units)
Table 95 Poultry Vaccines Market, by Region, 2022-2029 (Million Units)
Table 96 Bovine Vaccines Market, by Region, 2022-2029 (Million Units)
Table 97 Small Ruminant Vaccines Market, by Region, 2022-2029 (Million Units)
Table 98 Canine Vaccines Market, by Region, 2022-2029 (Million Units)
Table 99 Feline Vaccines Market, by Region, 2022-2029 (Million Units)
Table 100 Aquaculture Vaccines Market, by Region, 2022-2029 (Million Units)
Table 101 Asia-Pacific: Veterinary Vaccines Market, by Country, 2022-2029 (USD Million)
Table 102 Asia-Pacific: Veterinary Vaccines Market, by Type, 2022-2029 (USD Million)
Table 104 Asia-Pacific: Livestock Vaccines Market, by Type, 2022-2029 (USD Million)
Table 105 Asia-Pacific: Companion Animal Vaccines Market, by Type, 2022-2029 (USD Million)
Table 106 Asia-Pacific: Veterinary Vaccines Market, by Disease, 2022-2029 (USD Million)
Table 107 Asia-Pacific: Veterinary Vaccines Market for Livestock Diseases, by Type, 2022-2029 (USD Million)
Table 108 Asia-Pacific: Veterinary Vaccines Market for Companion Animal Diseases, by Type, 2022-2029 (USD Million)
Table 109 Asia-Pacific: Veterinary Vaccines Market, by Technology, 2022-2029 (USD Million)
Table 111 Asia-Pacific: Veterinary Vaccines Market, by Route of Administration, 2022-2029 (USD Million)
Table 112 Asia-Pacific: Veterinary Vaccines Market, by End-user, 2022-2029 (USD Million)
Table 113 Number of Veterinarians in Key Asia-Pacific Countries, 2022
Table 114 China: Veterinary Vaccines Market, by Type, 2022-2029 (USD Million)
Table 115 China: Livestock Vaccines Market, by Type, 2022-2029 (USD Million)
Table 116 China: Companion Animal Vaccines Market, by Type, 2022-2029 (USD Million)
Table 117 China: Veterinary Vaccines Market, by Disease, 2022-2029 (USD Million)
Table 118 China: Veterinary Vaccines Market for Livestock Diseases, by Type, 2022-2029 (USD Million)
Table 119 China: Veterinary Vaccines Market for Companion Animal Diseases, by Type, 2022-2029 (USD Million)
Table 120 China: Veterinary Vaccines Market, by Technology, 2022-2029 (USD Million)
Table 121 China: Veterinary Vaccines Market, by Route of Administration, 2022-2029 (USD Million)
Table 122 China: Veterinary Vaccines Market, by End-user, 2022-2029 (USD Million)
Table 123 Japan: Production and Consumption of Animal-Derived Food Products, 2000 vs. 2030 (Thousand Metric Tons)
Table 124 Japan: Veterinary Vaccines Market, by Type, 2022-2029 (USD Million)
Table 125 Japan: Livestock Vaccines Market, by Type, 2022-2029 (USD Million)
Table 126 Japan: Companion Animal Vaccines Market, by Type, 2022-2029 (USD Million)
Table 127 Japan: Veterinary Vaccines Market, by Disease, 2022-2029 (USD Million)
Table 128 Japan: Veterinary Vaccines Market for Livestock Diseases, by Type, 2022-2029 (USD Million)
Table 129 Japan: Veterinary Vaccines Market for Companion Animal Diseases, by Type, 2022-2029 (USD Million)
Table 130 Japan: Veterinary Vaccines Market, by Technology, 2022-2029 (USD Million)
Table 131 Japan: Veterinary Vaccines Market, by Route of Administration, 2022-2029 (USD Million)
Table 132 Japan: Veterinary Vaccines Market, by End-user, 2022-2029 (USD Million)
Table 133 India: Production and Consumption of Animal-Derived Food Products, 2000 vs. 2030 (Thousand Metric Tons)
Table 134 India: Veterinary Vaccines Market, by Type, 2022-2029 (USD Million)
Table 135 India: Livestock Vaccines Market, by Type, 2022-2029 (USD Million)
Table 136 India: Companion Animal Vaccines Market, by Type, 2022-2029 (USD Million)
Table 137 India: Veterinary Vaccines Market, by Disease, 2022-2029 (USD Million)
Table 138 India: Veterinary Vaccines Market for Livestock Diseases, by Type, 2022-2029 (USD Million)
Table 139 India: Veterinary Vaccines Market for Companion Animal Diseases, by Type, 2022-2029 (USD Million)
Table 140 India: Veterinary Vaccines Market, by Technology, 2022-2029 (USD Million)
Table 141 India: Veterinary Vaccines Market, by Route of Administration, 2022-2029 (USD Million)
Table 142 India: Veterinary Vaccines Market, by End-user, 2022-2029 (USD Million)
Table 143 Australia: Veterinary Vaccines Market, by Type, 2022-2029 (USD Million)
Table 144 Australia: Livestock Vaccines Market, by Type, 2022-2029 (USD Million)
Table 145 Australia: Companion Animal Vaccines Market, by Type, 2022-2029 (USD Million)
Table 146 Australia: Veterinary Vaccines Market, by Disease, 2022-2029 (USD Million)
Table 147 Australia: Veterinary Vaccines Market for Livestock Diseases, by Type, 2022-2029 (USD Million)
Table 148 Australia: Veterinary Vaccines Market for Companion Animal Diseases, by Type, 2022-2029 (USD Million)
Table 149 Australia: Veterinary Vaccines Market, by Technology, 2022-2029 (USD Million)
Table 150 Australia: Veterinary Vaccines Market, by Route of Administration, 2022-2029 (USD Million)
Table 151 Australia: Veterinary Vaccines Market, by End-user, 2022-2029 (USD Million)
Table 152 South Korea: Veterinary Vaccines Market, by Type, 2022-2029 (USD Million)
Table 153 South Korea: Livestock Vaccines Market, by Type, 2022-2029 (USD Million)
Table 154 South Korea: Companion Animal Vaccines Market, by Type, 2022-2029 (USD Million)
Table 155 South Korea: Veterinary Vaccines Market, by Disease, 2022-2029 (USD Million)
Table 156 South Korea: Veterinary Vaccines Market for Livestock Diseases, by Type, 2022-2029 (USD Million)
Table 157 South Korea: Veterinary Vaccines Market for Companion Animal Diseases, by Type, 2022-2029 (USD Million)
Table 158 South Korea: Veterinary Vaccines Market, by Technology, 2022-2029 (USD Million)
Table 159 South Korea: Veterinary Vaccines Market, by Route of Administration, 2022-2029 (USD Million)
Table 160 South Korea: Veterinary Vaccines Market, by End-user, 2022-2029 (USD Million)
Table 161 New Zealand: Veterinary Vaccines Market, by Type, 2022-2029 (USD Million)
Table 162 New Zealand: Livestock Vaccines Market, by Type, 2022-2029 (USD Million)
Table 163 New Zealand: Companion Animal Vaccines Market, by Type, 2022-2029 (USD Million)
Table 164 New Zealand: Veterinary Vaccines Market, by Disease, 2022-2029 (USD Million)
Table 165 New Zealand: Veterinary Vaccines Market for Livestock Diseases, by Type, 2022-2029 (USD Million)
Table 166 New Zealand: Veterinary Vaccines Market for Companion Animal Diseases, by Type, 2022-2029 (USD Million)
Table 167 New Zealand: Veterinary Vaccines Market, by Technology, 2022-2029 (USD Million)
Table 168 New Zealand: Veterinary Vaccines Market, by Route of Administration, 2022-2029 (USD Million)
Table 169 New Zealand: Veterinary Vaccines Market, by End-user, 2022-2029 (USD Million)
Table 170 Rest of Asia-Pacific: Veterinary Vaccines Market, by Type, 2022-2029 (USD Million)
Table 171 Rest of Asia-Pacific: Livestock Vaccines Market, by Type, 2022-2029 (USD Million)
Table 172 Rest of Asia-Pacific: Companion Animal Vaccines Market, by Type, 2022-2029 (USD Million)
Table 173 Rest of Asia-Pacific: Veterinary Vaccines Market, by Disease, 2022-2029 (USD Million)
Table 174 Rest of Asia-Pacific: Veterinary Vaccines Market for Livestock Diseases, by Type, 2022-2029 (USD Million)
Table 175 Rest of Asia-Pacific: Veterinary Vaccines Market for Companion Animal Diseases, by Type, 2022-2029 (USD Million)
Table 176 Rest of Asia-Pacific: Veterinary Vaccines Market, by Technology, 2022-2029 (USD Million)
Table 177 Rest of Asia-Pacific: Veterinary Vaccines Market, by Route of Administration, 2022-2029 (USD Million)
Table 178 Rest of Asia-Pacific: Veterinary Vaccines Market, by End-user, 2022-2029 (USD Million)
Table 179 North America: Veterinary Vaccines Market, by Country, 2022-2029 (USD Million)
Table 180 North America: Veterinary Vaccines Market, by Type, 2022-2029 (USD Million)
Table 181 North America: Livestock Vaccines Market, by Type, 2022-2029 (USD Million)
Table 182 North America: Companion Animal Vaccines Market, by Type, 2022-2029 (USD Million)
Table 183 North America: Veterinary Vaccines Market, by Disease, 2022-2029 (USD Million)
Table 184 North America: Veterinary Vaccines Market for Livestock Diseases, by Type, 2022-2029 (USD Million)
Table 185 North America: Veterinary Vaccines Market for Companion Animal Diseases, by Type, 2022-2029 (USD Million)
Table 186 North America: Veterinary Vaccines Market, by Technology, 2022-2029 (USD Million)
Table 187 North America: Veterinary Vaccines Market, by Route of Administration, 2022-2029 (USD Million)
Table 188 North America: Veterinary Vaccines Market, by End-user, 2022-2029 (USD Million)
Table 189 Number of Veterinarians in US and Canada, 2022
Table 190 Pet Industry Expenditure in US, 2018-2024 (USD Billion)
Table 191 US: Veterinary Vaccines Market, by Type, 2022-2029 (USD Million)
Table 192 US: Livestock Vaccines Market, by Type, 2022-2029 (USD Million)
Table 193 US: Companion Animal Vaccines Market, by Type, 2022-2029 (USD Million)
Table 194 US: Veterinary Vaccines Market, by Disease, 2022-2029 (USD Million)
Table 195 US: Veterinary Vaccines Market for Livestock Diseases, by Type, 2022-2029 (USD Million)
Table 196 US: Veterinary Vaccines Market for Companion Animal Diseases, by Type, 2022-2029 (USD Million)
Table 197 US: Veterinary Vaccines Market, by Technology, 2022-2029 (USD Million)
Table 198 US: Veterinary Vaccines Market, by Route of Administration, 2022-2029 (USD Million)
Table 199 US: Veterinary Vaccines Market, by End-user, 2022-2029 (USD Million)
Table 200 Canada: Veterinary Vaccines Market, by Type, 2022-2029 (USD Million)
Table 201 Canada: Livestock Vaccines Market, by Type, 2022-2029 (USD Million)
Table 202 Canada: Companion Animal Vaccines Market, by Type, 2022-2029 (USD Million)
Table 203 Canada: Veterinary Vaccines Market, by Disease, 2022-2029 (USD Million)
Table 204 Canada: Veterinary Vaccines Market for Livestock Diseases, by Type, 2022-2029 (USD Million)
Table 205 Canada: Veterinary Vaccines Market for Companion Animal Diseases, by Type, 2022-2029 (USD Million)
Table 206 Canada: Veterinary Vaccines Market, by Technology, 2022-2029 (USD Million)
Table 207 Canada: Veterinary Vaccines Market, by Route of Administration, 2022-2029 (USD Million)
Table 208 Canada: Veterinary Vaccines Market, by End-user, 2022-2029 (USD Million)
Table 209 Europe: Veterinary Vaccines Market, by Country, 2022-2029 (USD Million)
Table 210 Europe: Veterinary Vaccines Market, by Type, 2022-2029 (USD Million)
Table 211 Europe: Livestock Vaccines Market, by Type, 2022-2029 (USD Million)
Table 212 Europe: Companion Animal Vaccines Market, by Type, 2022-2029 (USD Million)
Table 213 Europe: Veterinary Vaccines Market, by Disease, 2022-2029 (USD Million)
Table 214 Europe: Veterinary Vaccines Market for Livestock Diseases, by Type, 2022-2029 (USD Million)
Table 215 Europe: Veterinary Vaccines Market for Companion Animal Diseases, by Type, 2022-2029 (USD Million)
Table 216 Europe: Veterinary Vaccines Market, by Technology, 2022-2029 (USD Million)
Table 217 Europe: Veterinary Vaccines Market, by Route of Administration, 2022-2029 (USD Million)
Table 218 Europe: Veterinary Vaccines Market, by End-user, 2022-2029 (USD Million)
Table 219 Number of Veterinarians in Europe, 2022
Table 220 Germany: Veterinary Vaccines Market, by Type, 2022-2029 (USD Million)
Table 221 Germany: Livestock Vaccines Market, by Type, 2022-2029 (USD Million)
Table 222 Germany: Companion Animal Vaccines Market, by Type, 2022-2029 (USD Million)
Table 223 Germany: Veterinary Vaccines Market, by Disease, 2022-2029 (USD Million)
Table 224 Germany: Veterinary Vaccines Market for Livestock Diseases, by Type, 2022-2029 (USD Million)
Table 225 Germany: Veterinary Vaccines Market for Companion Animal Diseases, by Type, 2022-2029 (USD Million)
Table 226 Germany: Veterinary Vaccines Market, by Technology, 2022-2029 (USD Million)
Table 227 Germany: Veterinary Vaccines Market, by Route of Administration, 2022-2029 (USD Million)
Table 228 Germany: Veterinary Vaccines Market, by End-user, 2022-2029 (USD Million)
Table 229 Pet Population in UK, 2024
Table 230 UK: Veterinary Vaccines Market, by Type, 2022-2029 (USD Million)
Table 231 UK: Livestock Vaccines Market, by Type, 2022-2029 (USD Million)
Table 232 UK: Companion Animal Vaccines Market, by Type, 2022-2029 (USD Million)
Table 233 UK: Veterinary Vaccines Market, by Disease, 2022-2029 (USD Million)
Table 234 UK: Veterinary Vaccines Market for Livestock Diseases, by Type, 2022-2029 (USD Million)
Table 235 UK: Veterinary Vaccines Market for Companion Animal Diseases, by Type, 2022-2029 (USD Million)
Table 236 UK: Veterinary Vaccines Market, by Technology, 2022-2029 (USD Million)
Table 237 UK: Veterinary Vaccines Market, by Route of Administration, 2022-2029 (USD Million)
Table 238 UK: Veterinary Vaccines Market, by End-user, 2022-2029 (USD Million)
Table 239 France: Veterinary Vaccines Market, by Type, 2022-2029 (USD Million)
Table 240 France: Livestock Vaccines Market, by Type, 2022-2029 (USD Million)
Table 241 France: Companion Animal Vaccines Market, by Type, 2022-2029 (USD Million)
Table 242 France: Veterinary Vaccines Market, by Disease, 2022-2029 (USD Million)
Table 243 France: Veterinary Vaccines Market for Livestock Diseases, by Type, 2022-2029 (USD Million)
Table 244 France: Veterinary Vaccines Market for Companion Animal Diseases, by Type, 2022-2029 (USD Million)
Table 245 France: Veterinary Vaccines Market, by Technology, 2022-2029 (USD Million)
Table 246 France: Veterinary Vaccines Market, by Route of Administration, 2022-2029 (USD Million)
Table 247 France: Veterinary Vaccines Market, by End-user, 2022-2029 (USD Million)
Table 248 Italy: Veterinary Vaccines Market, by Type, 2022-2029 (USD Million)
Table 249 Italy: Livestock Vaccines Market, by Type, 2022-2029 (USD Million)
Table 250 Italy: Companion Animal Vaccines Market, by Type, 2022-2029 (USD Million)
Table 251 Italy: Veterinary Vaccines Market, by Disease, 2022-2029 (USD Million)
Table 252 Italy: Veterinary Vaccines Market for Livestock Diseases, by Type, 2022-2029 (USD Million)
Table 253 Italy: Veterinary Vaccines Market for Companion Animal Diseases, by Type, 2022-2029 (USD Million)
Table 254 Italy: Veterinary Vaccines Market, by Technology, 2022-2029 (USD Million)
Table 255 Italy: Veterinary Vaccines Market, by Route of Administration, 2022-2029 (USD Million)
Table 256 Italy: Veterinary Vaccines Market, by End-user, 2022-2029 (USD Million)
Table 257 Spain: Veterinary Vaccines Market, by Type, 2022-2029 (USD Million)
Table 258 Spain: Livestock Vaccines Market, by Type, 2022-2029 (USD Million)
Table 259 Spain: Companion Animal Vaccines Market, by Type, 2022-2029 (USD Million)
Table 260 Spain: Veterinary Vaccines Market, by Disease, 2022-2029 (USD Million)
Table 261 Spain: Veterinary Vaccines Market for Livestock Diseases, by Type, 2022-2029 (USD Million)
Table 262 Spain: Veterinary Vaccines Market for Companion Animal Diseases, by Type, 2022-2029 (USD Million)
Table 263 Spain: Veterinary Vaccines Market, by Technology, 2022-2029 (USD Million)
Table 264 Spain: Veterinary Vaccines Market, by Route of Administration, 2022-2029 (USD Million)
Table 265 Spain: Veterinary Vaccines Market, by End-user, 2022-2029 (USD Million)
Table 266 Netherlands: Veterinary Vaccines Market, by Type, 2022-2029 (USD Million)
Table 267 Netherlands: Livestock Vaccines Market, by Type, 2022-2029 (USD Million)
Table 268 Netherlands: Companion Animal Vaccines Market, by Type, 2022-2029 (USD Million)
Table 269 Netherlands: Veterinary Vaccines Market, by Disease, 2022-2029 (USD Million)
Table 270 Netherlands: Veterinary Vaccines Market for Livestock Diseases, by Type, 2022-2029 (USD Million)
Table 271 Netherlands: Veterinary Vaccines Market for Companion Animal Diseases, by Type, 2022-2029 (USD Million)
Table 272 Netherlands: Veterinary Vaccines Market, by Technology, 2022-2029 (USD Million)
Table 273 Netherlands: Veterinary Vaccines Market, by Route of Administration, 2022-2029 (USD Million)
Table 274 Netherlands: Veterinary Vaccines Market, by End-user, 2022-2029 (USD Million)
Table 275 Rest of Europe: Veterinary Vaccines Market, by Type, 2022-2029 (USD Million)
Table 276 Rest of Europe: Livestock Vaccines Market, by Type, 2022-2029 (USD Million)
Table 277 Rest of Europe: Companion Animal Vaccines Market, by Type, 2022-2029 (USD Million)
Table 278 Rest of Europe: Veterinary Vaccines Market, by Disease, 2022-2029 (USD Million)
Table 279 Rest of Europe: Veterinary Vaccines Market for Livestock Diseases, by Type, 2022-2029 (USD Million)
Table 280 Rest of Europe: Veterinary Vaccines Market for Companion Animal Diseases, by Type, 2022-2029 (USD Million)
Table 281 Rest of Europe: Veterinary Vaccines Market, by Technology, 2022-2029 (USD Million)
Table 282 Rest of Europe: Veterinary Vaccines Market, by Route of Administration, 2022-2029 (USD Million)
Table 283 Rest of Europe: Veterinary Vaccines Market, by End-user, 2022-2029 (USD Million)
Table 284 Latin America: Veterinary Vaccines Market, by Country, 2022-2029 (USD Million)
Table 285 Latin America: Veterinary Vaccines Market, by Type, 2022-2029 (USD Million)
Table 286 Latin America: Livestock Vaccines Market, by Type, 2022-2029 (USD Million)
Table 287 Latin America: Companion Animal Vaccines Market, by Type, 2022-2029 (USD Million)
Table 288 Latin America: Veterinary Vaccines Market, by Disease, 2022-2029 (USD Million)
Table 289 Latin America: Veterinary Vaccines Market for Livestock Diseases, by Type, 2022-2029 (USD Million)
Table 290 Latin America: Veterinary Vaccines Market for Companion Animal Diseases, by Type, 2022-2029 (USD Million)
Table 291 Latin America: Veterinary Vaccines Market, by Technology, 2022-2029 (USD Million)
Table 292 Latin America: Veterinary Vaccines Market, by Route of Administration, 2022-2029 (USD Million)
Table 293 Latin America: Veterinary Vaccines Market, by End-user, 2022-2029 (USD Million)
Table 294 Brazil: Veterinary Vaccines Market, by Type, 2022-2029 (USD Million)
Table 295 Brazil: Livestock Vaccines Market, by Type, 2022-2029 (USD Million)
Table 296 Brazil: Companion Animal Vaccines Market, by Type, 2022-2029 (USD Million)
Table 297 Brazil: Veterinary Vaccines Market, by Disease, 2022-2029 (USD Million)
Table 298 Brazil: Veterinary Vaccines Market for Livestock Diseases, by Type, 2022-2029 (USD Million)
Table 299 Brazil: Veterinary Vaccines Market for Companion Animal Diseases, by Type, 2022-2029 (USD Million)
Table 300 Brazil: Veterinary Vaccines Market, by Technology, 2022-2029 (USD Million)
Table 301 Brazil: Veterinary Vaccines Market, by Route of Administration, 2022-2029 (USD Million)
Table 302 Brazil: Veterinary Vaccines Market, by End-user, 2022-2029 (USD Million)
Table 303 Mexico: Veterinary Vaccines Market, by Type, 2022-2029 (USD Million)
Table 304 Mexico: Livestock Vaccines Market, by Type, 2022-2029 (USD Million)
Table 305 Mexico: Companion Animal Vaccines Market, by Type, 2022-2029 (USD Million)
Table 306 Mexico: Veterinary Vaccines Market, by Disease, 2022-2029 (USD Million)
Table 307 Mexico: Veterinary Vaccines Market for Livestock Diseases, by Type, 2022-2029 (USD Million)
Table 308 Mexico: Veterinary Vaccines Market for Companion Animal Diseases, by Type, 2022-2029 (USD Million)
Table 309 Mexico: Veterinary Vaccines Market, by Technology, 2022-2029 (USD Million)
Table 310 Mexico: Veterinary Vaccines Market, by Route of Administration, 2022-2029 (USD Million)
Table 311 Mexico: Veterinary Vaccines Market, by End-user, 2022-2029 (USD Million)
Table 312 Rest of Latin America: Veterinary Vaccines Market, by Type, 2022-2029 (USD Million)
Table 313 Rest of Latin America: Livestock Vaccines Market, by Type, 2022-2029 (USD Million)
Table 314 Rest of Latin America: Companion Animal Vaccines Market, by Type, 2022-2029 (USD Million)
Table 315 Rest of Latin America: Veterinary Vaccines Market, by Disease, 2022-2029 (USD Million)
Table 316 Rest of Latin America: Veterinary Vaccines Market for Livestock Diseases, by Type, 2022-2029 (USD Million)
Table 317 Rest of Latin America: Veterinary Vaccines Market for Companion Animal Diseases, by Type, 2022-2029 (USD Million)
Table 318 Rest of Latin America: Veterinary Vaccines Market, by Technology, 2022-2029 (USD Million)
Table 319 Rest of Latin America: Veterinary Vaccines Market, by Route of Administration, 2022-2029 (USD Million)
Table 320 Rest of Latin America: Veterinary Vaccines Market, by End-user, 2022-2029 (USD Million)
Table 321 Middle East & Africa: Veterinary Vaccines Market, by Country, 2022-2029 (USD Million)
Table 322 Middle East & Africa: Veterinary Vaccines Market, by Type, 2022-2029 (USD Million)
Table 323 Middle East & Africa: Livestock Vaccines Market, by Type, 2022-2029 (USD Million)
Table 324 Middle East & Africa: Companion Animal Vaccines Market, by Type, 2022-2029 (USD Million)
Table 325 Middle East & Africa: Veterinary Vaccines Market, by Disease, 2022-2029 (USD Million)
Table 326 Middle East & Africa: Veterinary Vaccines Market for Livestock Diseases, by Type, 2022-2029 (USD Million)
Table 327 Middle East & Africa: Veterinary Vaccines Market for Companion Animal Diseases, by Type, 2022-2029 (USD Million)
Table 328 Middle East & Africa: Veterinary Vaccines Market, by Technology, 2022-2029 (USD Million)
Table 329 Middle East & Africa: Veterinary Vaccines Market, by Route of Administration, 2022-2029 (USD Million)
Table 330 Middle East & Africa: Veterinary Vaccines Market, by End-user, 2022-2029 (USD Million)
Table 331 GCC Countries: Veterinary Vaccines Market, by Country, 2022-2029 (USD Million)
Table 332 GCC Countries: Veterinary Vaccines Market, by Type, 2022-2029 (USD Million)
Table 333 GCC Countries: Livestock Vaccines Market, by Type, 2022-2029 (USD Million)
Table 334 GCC Countries: Companion Animal Vaccines Market, by Type, 2022-2029 (USD Million)
Table 335 GCC Countries: Veterinary Vaccines Market, by Disease, 2022-2029 (USD Million)
Table 336 GCC Countries: Veterinary Vaccines Market for Livestock Diseases, by Type, 2022-2029 (USD Million)
Table 337 GCC Countries: Veterinary Vaccines Market for Companion Animal Diseases, by Type, 2022-2029 (USD Million)
Table 338 GCC Countries: Veterinary Vaccines Market, by Technology, 2022-2029 (USD Million)
Table 339 GCC Countries: Veterinary Vaccines Market, by Route of Administration, 2022-2029 (USD Million)
Table 340 GCC Countries: Veterinary Vaccines Market, by End-user, 2022-2029 (USD Million)
Table 341 Kingdom of Saudi Arabia: Veterinary Vaccines Market, by Type, 2022-2029 (USD Million)
Table 342 Kingdom of Saudi Arabia: Livestock Vaccines Market, by Type, 2022-2029 (USD Million)
Table 343 Kingdom of Saudi Arabia: Companion Animal Vaccines Market, by Type, 2022-2029 (USD Million)
Table 344 Kingdom of Saudi Arabia: Veterinary Vaccines Market, by Disease, 2022-2029 (USD Million)
Table 345 Kingdom of Saudi Arabia: Veterinary Vaccines Market for Livestock Diseases, by Type, 2022-2029 (USD Million)
Table 346 Kingdom of Saudi Arabia: Veterinary Vaccines Market for Companion Animal Diseases, by Type, 2022-2029 (USD Million)
Table 347 Kingdom of Saudi Arabia: Veterinary Vaccines Market, by Technology, 2022-2029 (USD Million)
Table 348 Kingdom of Saudi Arabia: Veterinary Vaccines Market, by Route of Administration, 2022-2029 (USD Million)
Table 349 Kingdom of Saudi Arabia: Veterinary Vaccines Market, by End-user, 2022-2029 (USD Million)
Table 350 UAE: Veterinary Vaccines Market, by Type, 2022-2029 (USD Million)
Table 351 UAE: Livestock Vaccines Market, by Type, 2022-2029 (USD Million)
Table 352 UAE: Companion Animal Vaccines Market, by Type, 2022-2029 (USD Million)
Table 353 UAE: Veterinary Vaccines Market, by Disease, 2022-2029 (USD Million)
Table 354 UAE: Veterinary Vaccines Market for Livestock Diseases, by Type, 2022-2029 (USD Million)
Table 355 UAE: Veterinary Vaccines Market for Companion Animal Diseases, by Type, 2022-2029 (USD Million)
Table 356 UAE: Veterinary Vaccines Market, by Technology, 2022-2029 (USD Million)
Table 357 UAE: Veterinary Vaccines Market, by Route of Administration, 2022-2029 (USD Million)
Table 358 UAE: Veterinary Vaccines Market, by End-user, 2022-2029 (USD Million)
Table 359 Rest of GCC Countries: Veterinary Vaccines Market, by Type, 2022-2029 (USD Million)
Table 360 Rest of GCC Countries: Livestock Vaccines Market, by Type, 2022-2029 (USD Million)
Table 361 Rest of GCC Countries: Companion Animal Vaccines Market, by Type, 2022-2029 (USD Million)
Table 362 Rest of GCC Countries: Veterinary Vaccines Market, by Disease, 2022-2029 (USD Million)
Table 363 Rest of GCC Countries: Veterinary Vaccines Market for Livestock Diseases, by Type, 2022-2029 (USD Million)
Table 364 Rest of GCC Countries: Veterinary Vaccines Market for Companion Animal Diseases, by Type, 2022-2029 (USD Million)
Table 365 Rest of GCC Countries: Veterinary Vaccines Market, by Technology, 2022-2029 (USD Million)
Table 366 Rest of GCC Countries: Veterinary Vaccines Market, by Route of Administration, 2022-2029 (USD Million)
Table 367 Rest of GCC Countries: Veterinary Vaccines Market, by End-user, 2022-2029 (USD Million)
Table 368 Rest of Middle East & Africa: Veterinary Vaccines Market, by Type, 2022-2029 (USD Million)
Table 369 Rest of Middle East & Africa: Livestock Vaccines Market, by Type, 2022-2029 (USD Million)
Table 370 Rest of Middle East & Africa: Companion Animal Vaccines Market, by Type, 2022-2029 (USD Million)
Table 371 Rest of Middle East & Africa: Veterinary Vaccines Market, by Disease, 2022-2029 (USD Million)
Table 372 Rest of Middle East & Africa: Veterinary Vaccines Market for Livestock Diseases, by Type, 2022-2029 (USD Million)
Table 373 Rest of Middle East & Africa: Veterinary Vaccines Market for Companion Animal Diseases, by Type, 2022-2029 (USD Million)
Table 374 Rest of Middle East & Africa Veterinary Vaccines Market, by Technology, 2022-2029 (USD Million)
Table 375 Rest of Middle East & Africa: Veterinary Vaccines Market, by Route of Administration, 2022-2029 (USD Million)
Table 376 Rest of Middle East & Africa: Veterinary Vaccines Market, by End-user, 2022-2029 (USD Million)
Table 377 Overview of Strategies Adopted by Key Players in Veterinary Vaccines Market
Table 378 Veterinary Vaccines Market: Degree of Competition
Table 379 Veterinary Vaccines Market: Region Footprint
Table 380 Veterinary Vaccines Market: Type Footprint
Table 381 Veterinary Vaccines Market: Disease Footprint
Table 382 Veterinary Vaccines Market: Technology Footprint
Table 383 Veterinary Vaccines Market: Detailed List of Key Startups/SMEs
Table 384 Veterinary Vaccines Market: Competitive Benchmarking of Key Startups/SMEs
Table 385 Veterinary Vaccines Market: Product Launches & Approvals, January 2021-December 2024
Table 386 Veterinary Vaccines Market: Deals, January 2021-December 2024
Table 387 Veterinary Vaccines Market: Expansions, January 2021-December 2024
Table 388 Veterinary Vaccines Market: Other Developments, January 2021-December 2024
Table 389 Merck & Co. Inc.: Company Overview
Table 390 Merck & Co. Inc.: Products Offered
Table 391 Merck & Co. Inc.: Product Launches & Approvals, January 2021-December 2024
Table 392 Merck & Co. Inc.: Deals, January 2021-December 2024
Table 393 Merck & Co. Inc.: Expansions, January 2021-December 2024
Table 394 Merck & Co. Inc.: Other Developments, January 2021- December 2024
Table 395 Zoetis: Company Overview
Table 396 Zoetis: Products Offered
Table 397 Zoetis: Product Launches, January 2021-December 2024
Table 398 Zoetis: Deals, January 2021-December 2024
Table 399 Zoetis: Expansions, January 2021-December 2024
Table 400 Zoetis: Other Developments, January 2021-December 2024
Table 401 Boehringer Ingelheim International GmbH: Company Overview
Table 402 Boehringer Ingelheim International GmbH: Products Offered
Table 403 Boehringer Ingelheim International GmbH: Product Launches, January 2021-December 2024
Table 404 Boehringer Ingelheim International GmbH: Expansions, January 2021-December 2024
Table 405 Elanco: Company Overview
Table 406 Elanco: Products Offered
Table 407 Elanco: Deals, January 2021-December 2024
Table 408 Ceva: Company Overview
Table 409 Ceva: Products Offered
Table 410 Ceva: Deals, January 2021-December 2024
Table 411 Ceva: Expansions, January 2021-December 2024
Table 412 Virbac: Company Overview
Table 413 Virbac: Products Offered
Table 414 Virbac: Product Launches, January 2021-December 2024
Table 415 Virbac: Deals, January 2021-December 2024
Table 416 Virbac: Expansions, January 2021-December 2024
Table 417 Virbac: Other Developments, January 2021-December 2024
Table 418 Phibro Animal Health Corporation: Company Overview
Table 419 Phibro Animal Health Corporation: Products Offered
Table 420 Hester Biosciences Limited: Company Overview
Table 421 Hester Biosciences Limited: Products Offered
Table 422 Hester Biosciences Limited: Deals, January 2021-December 2024
Table 423 Neogen Corporation: Company Overview
Table 424 Neogen Corporation: Products Offered
Table 425 Neogen Corporation: Deals, January 2021-December 2024
Table 426 Hipra: Company Overview
Table 427 Hipra: Products Offered
Table 428 Hipra: Product Launches, January 2021-December 2024
Table 429 Biogénesis Bagó: Company Overview
Table 430 Biogénesis Bagó: Products Offered
Table 431 Biogénesis Bagó: Expansions, January 2021-December 2024
Table 432 Tianjin Ringpu Bio-Technology Co. Ltd.: Company Overview
Table 433 Tianjin Ringpu Bio-Technology Co. Ltd.: Products Offered
Table 434 Tianjin Ringpu Bio-Technology Co. Ltd.: Deals, January 2021- December 2024
Table 435 China Animal Husbandry Industry Co. Ltd.: Company Overview
Table 436 China Animal Husbandry Industry Co. Ltd.: Products Offered
Table 437 Jinyu Bio-Technology Co. Ltd.: Company Overview
Table 438 Jinyu Bio-Technology Co. Ltd.: Products Offered
Table 439 Jinyu Bio-Technology Co. Ltd.: Product Approvals, January 2021-December 2024
Table 440 Vaxxinova International B.V.: Company Overview
Table 441 Vaxxinova International B.V.: Products Offered
Table 442 Vaxxinova International B.V.: Product Approvals, January 2021-December 2024
Table 443 Vaxxinova International B.V.: Expansions, January 2021-December 2024
Table 444 Endovac Animal Health: Company Overview
Table 445 Brilliant Bio Pharma: Company Overview
Table 446 Aptimmune: Company Overview
Table 447 Indian Immunologicals Ltd.: Company Overview
Table 448 Torigen Pharmaceuticals Inc.: Company Overview
Table 449 Intas Pharmaceuticals Ltd.: Company Overview
Table 450 Ourofino Animal Health: Company Overview
Table 451 Biovac Ltd.: Company Overview
Table 452 Laboratoire Lcv: Company Overview
Table 453 Kyoritsu Seiyaku Corporation: Company Overview

Figure 1 Veterinary Vaccines Market Segmentation & Geographical Spread
Figure 2 Veterinary Vaccines Market: Years Considered
Figure 3 Veterinary Vaccines Market: Research Design
Figure 4 Veterinary Vaccines Market: Key Data from Secondary Sources
Figure 5 Veterinary Vaccines Market: Key Primary Sources
Figure 6 Veterinary Vaccines Market: Key Data from Primary Sources
Figure 7 Veterinary Vaccines Market: Key Industry Insights
Figure 8 Breakdown of Primaries: Supply- and Demand-Side Participants
Figure 9 Breakdown of Primaries (Supply-Side Participants): by Company Type, Designation, and Region
Figure 10 Breakdown of Primaries (Demand-Side Participants): by End-user, Designation, and Region
Figure 11 Veterinary Vaccines Market: Supply-Side Market Size Estimation Process
Figure 12 Veterinary Vaccines Market: Revenue Share Illustration for Zoetis (2023)
Figure 13 Veterinary Vaccines Market: Total Revenue Analysis (2023)
Figure 14 Veterinary Vaccines Market: CAGR Projection from Analysis of Drivers, Restraints, Opportunities, and Challenges
Figure 15 CAGR Projection: Supply-Side Analysis
Figure 16 Veterinary Vaccines Market: Top-Down Approach
Figure 17 Veterinary Vaccines Market: Data Triangulation
Figure 18 Veterinary Vaccines Market, by Type, 2024 vs. 2029 (USD Million)
Figure 19 Veterinary Vaccines Market, by Disease, 2024 vs. 2029 (USD Million)
Figure 20 Veterinary Vaccines Market, by Technology, 2024 vs. 2029 (USD Million)
Figure 21 Veterinary Vaccines Market, by Route of Administration, 2024 vs. 2029 (USD Million)
Figure 22 Veterinary Vaccines Market, by End-user, 2024 vs. 2029 (USD Million)
Figure 23 Veterinary Vaccines Market: Regional Snapshot
Figure 24 Increasing Companion Animal Population and Rising Incidence of Zoonotic Diseases to Drive Market
Figure 25 China and Live Attenuated Vaccines Commanded Largest Market Share in 2023
Figure 26 China to Witness Highest CAGR from 2024 to 2029
Figure 27 Veterinary Vaccines Market: Drivers, Restraints, Opportunities, and Challenges
Figure 28 Pet Population in Major Markets in 2022 (Million)
Figure 29 Veterinary Vaccines Market: Trends/Disruptions Impacting Customer's Business
Figure 30 Veterinary Vaccines Market: Supply Chain Analysis
Figure 31 Veterinary Vaccines Market: Value Chain Analysis
Figure 32 Veterinary Vaccines Market: Porter's Five Forces Analysis
Figure 33 Influence of Key Stakeholders on Buying Process, by End-user
Figure 34 Key Buying Criteria for End-users
Figure 35 Top Applicants/Owners (Companies/Institutions) for Veterinary Vaccine Patents (January 2014-November 2024)
Figure 36 Average Selling Price of Livestock Vaccines, by Key Player, 2023 (USD)
Figure 37 Average Selling Price of Porcine Vaccines, by Key Player, 2023 (USD)
Figure 38 Veterinary Vaccines Market: Ecosystem Analysis
Figure 39 Veterinary Vaccines Market: Number of Deals and Value of Investments, 2018-2022
Figure 40 Asia-Pacific: Veterinary Vaccines Market Snapshot
Figure 41 Cat Population Across Key Asia-Pacific Countries (2024)
Figure 42 Expected Growth in Number of Veterinarians in North America
Figure 43 North America: Veterinary Vaccines Market Snapshot
Figure 44 Pet (Dog and Cat) Population in US and Canada (2022)
Figure 45 Pet (Dog and Cat) Population in Key European Countries (2022)
Figure 46 Pet (Dog and Cat) Population in Key Latin American Countries (2022)
Figure 47 Cat Population in Middle Eastern & African Countries (2022)
Figure 48 Veterinary Vaccines Market: Revenue Analysis of Top Five Players (2019-2023)
Figure 49 Market Share Analysis of Key Players in Veterinary Vaccines Market (2023)
Figure 50 Veterinary Vaccines Market: Ranking of Key Market Players (2023)
Figure 51 Veterinary Vaccines Market: Company Evaluation Matrix (Key Players), 2023
Figure 52 Veterinary Vaccines Market: Company Footprint
Figure 53 Veterinary Vaccines Market: Company Evaluation Matrix (Startups/SMEs), 2023
Figure 54 Veterinary Vaccines Market: Brand/Product Comparative Analysis
Figure 55 Veterinary Vaccines Market: R&D Expenditure of Key Players (2021-2023)
Figure 56 EV/EBITDA of Key Vendors
Figure 57 Year-To-Date (Ytd) Price Total Return and 5-Year Stock Beta of Key Vendors
Figure 58 Merck & Co. Inc.: Company Snapshot
Figure 59 Zoetis: Company Snapshot
Figure 60 Boehringer Ingelheim International GmbH: Company Snapshot
Figure 61 Elanco: Company Snapshot
Figure 62 Virbac: Company Snapshot
Figure 63 Phibro Animal Health Corporation: Company Snapshot
Figure 64 Hester Biosciences Limited: Company Snapshot
Figure 65 Neogen Corporation: Company Snapshot
Figure 66 Tianjin Ringpu Bio-Technology Co. Ltd.: Company Snapshot
Figure 67 Jinyu Bio-Technology Co. Ltd.: Company Snapshot